Metavesco Finalizes Major Share Reduction to Strengthen Capital Structure

Metavesco, Inc. has formally completed the reduction of its authorized common shares by 7.5 billion shares, a corporate action the company says underscores its focus on responsible capital structure management. The amendment has been processed and filed with the State of Nevada, making the reduction effective immediately.

The company, which trades on the OTC Markets under the symbol MVCO, first announced its intention to execute this reduction on December 1, 2025. CEO Ryan Schadel stated the action reflects the company's "continued focus on responsible capital structure management and long-term shareholder alignment." He emphasized the company's follow-through, saying, "We said we would do this, and we followed through."

This corporate governance move is significant for shareholders and market observers as it reduces the potential for future dilution. By lowering the total pool of shares the company is authorized to issue, Metavesco is signaling a more disciplined approach to its equity. The company expects the updated share structure to be reflected on otcmarkets.com in the coming days, though the change is already visible on the Nevada Secretary of State website.

The importance of this announcement extends beyond the immediate balance sheet adjustment. Metavesco positions itself as the architect of the OTCfi ecosystem, a suite of tools and digital platforms designed to modernize the over-the-counter markets. The company remains focused on building long-term value through its operating businesses, strategic investments, and the development of this ecosystem. The OTCfi token itself is built on the Solana blockchain and is intended to become a digital asset treasury token for OTC issuers. More information on this initiative can be found at otcfi.io.

For investors, the share reduction represents a tangible step toward aligning management's interests with those of shareholders, potentially increasing earnings per share metrics and improving capital efficiency. In the broader context of the OTC markets, which often face scrutiny over transparency and governance, such actions by issuers can contribute to improved market credibility. The company's broader corporate information is available at metavesco.com.

The completion of this planned reduction demonstrates executive commitment to stated corporate objectives. While the press release contains forward-looking statements subject to risks and uncertainties, the execution of this specific capital structure change is a completed, factual event with clear implications for the company's financial framework and its relationship with the investment community.